|
|
|
Insider
Information: |
Mannino Raphael J |
Relationship: |
Chief Scientific Officer |
City: |
Newark |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
2,132,324 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$1,531,921 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
2,132,324 |
|
|
Total
Value |
$1,531,921 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biodelivery Sciences Internation... |
BDSI |
Executive VP & CSO, Di... |
2008-01-31 |
212,609 |
2004-04-12 |
0 |
Premium* |
|
Matinas Biopharma Holdings, Inc. |
MTNB |
Chief Scientific Officer |
2021-09-03 |
1,919,715 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
MTNB |
Matinas Biopharma Holding... |
Chief Scientific Officer |
|
2021-09-03 |
4 |
A |
$0.00 |
$0 |
D/D |
462,150 |
1,919,715 |
0 |
- |
|
MTNB |
Matinas Biopharma Holding... |
Chief Scientific Officer |
|
2021-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
1,457,565 |
0 |
- |
|
MTNB |
Matinas Biopharma Holding... |
Chief Scientific Officer |
|
2021-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
1,437,565 |
0 |
- |
|
MTNB |
Matinas Biopharma Holding... |
Chief Scientific Officer |
|
2020-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
1,429,565 |
0 |
- |
|
MTNB |
Matinas Biopharma Holding... |
Chief Scientific Officer |
|
2019-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
1,426,565 |
0 |
- |
|
MTNB |
Matinas Biopharma Holding... |
Chief Scientific Officer |
|
2017-09-11 |
4 |
B |
$1.41 |
$7,050 |
D/D |
5,000 |
1,424,565 |
2.74 |
- |
|
MTNB |
Matinas Biopharma Holding... |
Chief Scientific OfficerOffice |
|
2017-03-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,419,565 |
|
- |
|
BDSI |
Biodelivery Sciences Inte... |
Executive VP & CSO |
|
2008-01-31 |
4 |
OE |
$1.63 |
$97,800 |
D/D |
60,000 |
212,609 |
0 |
- |
|
BDSI |
Biodelivery Sciences Inte... |
EVP & Chief Scientific officer |
|
2007-06-25 |
4 |
OE |
$1.70 |
$34,000 |
D/D |
20,000 |
152,609 |
0 |
- |
|
BDSI |
Biodelivery Sciences Inte... |
EVP & Chief Scientific Officer |
|
2007-06-12 |
4 |
S |
$4.82 |
$25,055 |
D/D |
(5,197) |
132,609 |
0 |
- |
|
BDSI |
Biodelivery Sciences Inte... |
EVP & Chief Scientific officer |
|
2007-06-06 |
4 |
S |
$5.03 |
$74,474 |
D/D |
(14,803) |
137,806 |
0 |
- |
|
BDSI |
Biodelivery Sciences Inte... |
Executive Vice President & CSO |
|
2004-04-12 |
4 |
S |
$3.97 |
$109,572 |
D/D |
(27,600) |
155,009 |
|
- |
|
12 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|